Sweden Real World Evidence Solutions Market Size & Outlook
Sweden real world evidence solutions market, 2018-2030 (US$M)
Related Markets
Sweden real world evidence solutions market highlights
- The Sweden real world evidence solutions market generated a revenue of USD 35.4 million in 2023 and is expected to reach USD 59.4 million by 2030.
- The Sweden market is expected to grow at a CAGR of 7.7% from 2024 to 2030.
- In terms of segment, services was the largest revenue generating component in 2023.
- Services is the most lucrative component segment registering the fastest growth during the forecast period.
Real world evidence solutions market data book summary
| Market revenue in 2023 | USD 35.4 million |
| Market revenue in 2030 | USD 59.4 million |
| Growth rate | 7.7% (CAGR from 2023 to 2030) |
| Largest segment | Services |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Data Sets |
| Key market players worldwide | IQVIA Holdings Inc, International Business Machines Corp, Thermo Fisher Scientific Inc, PAREXEL, PerkinElmer, Icon PLC, Oracle Corp, Syneos Health, Medpace Holdings Inc |
Other key industry trends
- In terms of revenue, Sweden accounted for 1.4% of the global real world evidence solutions market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany real world evidence solutions market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 352.8 million by 2030.
Services was the largest segment with a revenue share of 57.63% in 2023. Horizon Databook has segmented the Sweden real world evidence solutions market based on services, data sets covering the revenue growth of each sub-segment from 2018 to 2030.
The RWE market in Sweden is gaining traction. It is expected to grow at a lucrative rate over the forecast period owing to increasing investments by private and public players for research & development in this area. The RWE is becoming increasingly important in the healthcare community, and RWD analyses are key to generating such evidence.
The RWE is useful in supplementing clinical trial findings and addressing gaps in our knowledge regarding medication use in real-world medical settings. This data is sourced from de-identified patient-related information from various sources, such as claims databases, health surveys, anonymized Electronic Medical Records (EMRs), and patient registries.
The insights received from RWD analyses are valuable to a wide range of healthcare stakeholders. For instance, provider and payer organizations can leverage the data to understand better a medication's real-world effectiveness, safety, and cost. At the same time, healthcare practitioners may combine the data with randomized controlled clinical trials to inform their daily patient treatment decisions.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Real World Evidence Solutions Market Scope
Real World Evidence Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Sweden real world evidence solutions market size, by component, 2018-2030 (US$M)
Sweden Real World Evidence Solutions Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
